Defining prostate cancer risk before prostate biopsy

被引：21
|
作者：
Pal, Raj P. [1 ]
Maitra, Neil U. [1 ]
Mellon, J. Kilian [1 ]
Khan, Masood A. [1 ]
机构：
[1] Univ Hosp Leicester NHS Trust, Leicester Gen Hosp, Dept Urol, Leicester LE5 4PW, Leics, England
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2013年 / 31卷 / 08期
关键词：
Prostate cancer; Biopsy; Urine; Serum; Imaging; DIGITAL RECTAL EXAMINATION; MOLECULAR URINE ASSAY; COENZYME-A RACEMASE; TMPRSS2-ERG FUSION TRANSCRIPTS; ACID-PHOSPHATASE-ACTIVITY; METHYLACYL-COA RACEMASE; GLANDULAR KALLIKREIN 2; LONG-TERM PREDICTION; RADICAL PROSTATECTOMY; ANTIGEN PSA;
D O I：
10.1016/j.urolonc.2012.05.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Prostate cancer is the most commonly diagnosed cancer in men. At present, patients are selected for prostate biopsy on the basis of age, serum prostate specific antigen (PSA), and prostatic digital rectal examination (DRE) findings. However, due to limitations in the use of PSA and DRE, many patients undergo unnecessary prostate biopsy. A further problem arises as many patients are diagnosed and treated for indolent disease. This review of the literature highlights the strengths and weaknesses of existing methods of prebiopsy risk stratification and evaluates promising serum, urine, and radiologic prostate cancer biomarkers, which may improve risk stratification for prostate biopsy in the future. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码：1408 / 1418
页数：11
相关论文
共 50 条
  • [31] The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group
    Vickers, Andrew J.
    Cronin, Angel M.
    Roobol, Monique J.
    Hugosson, Jonas
    Jones, J. Stephen
    Kattan, Michael W.
    Klein, Eric
    Hamdy, Freddie
    Neal, David
    Donovan, Jenny
    Parekh, Dipen J.
    Ankerst, Donna
    Bartsch, George
    Klocker, Helmut
    Horninger, Wolfgang
    Benchikh, Amine
    Salama, Gilles
    Villers, Arnauld
    Freedland, Steve J.
    Moreira, Daniel M.
    Schroder, Fritz H.
    Lilja, Hans
    CLINICAL CANCER RESEARCH, 2010, 16 (17) : 4374 - 4381
  • [32] Baseline Prostate Atrophy is Associated with Reduced Risk of Prostate Cancer in Men Undergoing Repeat Prostate Biopsy
    Moreira, Daniel M.
    Bostwick, David G.
    Andriole, Gerald L.
    Peterson, Bercedis L.
    Cohen, Harvey J.
    Castro-Santamaria, Ramiro
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2015, 194 (05): : 1241 - 1246
  • [33] Baseline Prostate Inflammation Is Associated With a Reduced Risk of Prostate Cancer in Men Undergoing Repeat Prostate Biopsy
    Moreira, Daniel M.
    Nickel, J. Curtis
    Gerber, Leah
    Muller, Roberto L.
    Andriole, Gerald L.
    Castro-Santamaria, Ramiro
    Freedland, Stephen J.
    CANCER, 2014, 120 (02) : 190 - 196
  • [34] Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy
    Chen, Rui
    Xie, Liping
    Xue, Wei
    Ye, Zhangqun
    Ma, Lulin
    Gao, Xu
    Ren, Shancheng
    Wang, Fubo
    Zhao, Lin
    Xu, Chuanliang
    Sun, Yinghao
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (09) : 416.e1 - 416.e7
  • [35] Saturation biopsy of the prostate in the detection of prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 153 - 153
  • [36] Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?
    Bu Hyeon Yun
    Eu Chang Hwang
    Ho Song Yu
    Hoseok Chung
    Sun-Ouck Kim
    Seung Il Jung
    Taek won Kang
    Dong Deuk Kwon
    Kwangsung Park
    Chan Choi
    International Urology and Nephrology, 2015, 47 : 1251 - 1257
  • [37] Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?
    Yun, Bu Hyeon
    Hwang, Eu Chang
    Yu, Ho Song
    Chung, Hoseok
    Kim, Sun-Ouck
    Jung, Seung Il
    Kang, Taek Won
    Kwon, Dong Deuk
    Park, Kwangsung
    Choi, Chan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (08) : 1251 - 1257
  • [38] COMPLIANCE WITH BIOPSY RECOMMENDATIONS BY A PROSTATE CANCER RISK CALCULATOR
    Van Vugt, H. A.
    Roobol, M. J.
    Van Leeuwen, P. J.
    Steyerberg, E. W.
    Korfage, I
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 35 - 35
  • [39] Compliance with biopsy recommendations of a prostate cancer risk calculator
    van Vugt, Heidi A.
    Roobol, Monique J.
    Busstra, Martijn
    Kil, Paul
    Oomens, Eric H.
    de Jong, Igle J.
    Bangma, Chris H.
    Steyerberg, Ewout W.
    Korfage, Ida
    BJU INTERNATIONAL, 2012, 109 (10) : 1480 - 1488
  • [40] Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance
    Salguero, Joseba
    Gomez-Gomez, Enrique
    Valero-Rosa, Jose
    Carrasco-Valiente, Julia
    Mesa, Juan
    Martin, Cristina
    Campos-Hernandez, Juan Pablo
    Rubio, Juan Manuel
    Lopez, Daniel
    Requena, Maria Jose
    KOREAN JOURNAL OF RADIOLOGY, 2021, 22 (04) : 559 - 567
12345